Duract (bromfenac) was on the market less than a year
Duract (bromfenac) was on the market less than a year.
This NSAID worked well for acute pain, but got pulled becauseof reports of severe hepatic failure in patients who used Duract formore than 10 days or had pre-existing hepatic disease.
In fact, its labeling had a black-box warning not to take itfor more than 10 days because of the risk of hepatic toxicity.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote